Sepsis (peds): Difference between revisions
Ostermayer (talk | contribs) |
|||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Peds top}} [[Sepsis]].'' | ||
==Background== | ==Background== | ||
*Defined as a dysregulated host response to infection that leads to life-threatening organ dysfunction<ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | |||
*Tachycardia is typically most predominant, hypotension is a late and ominous sign | *Tachycardia is typically most predominant, hypotension is a late and ominous sign | ||
==Clinical Features== | ==Clinical Features== | ||
| Line 32: | Line 23: | ||
| Pulse Pressure || Widen || Narrow | | Pulse Pressure || Widen || Narrow | ||
|} | |} | ||
===Neonatal Sepsis=== | |||
*Early onset | |||
**First few days of life | |||
**Fulminant, associated with maternal or perinatal risk factors | |||
**[[Septic shock]] and [[neutropenia]] are more common | |||
*Late onset | |||
**Occurs after 1 week of age | |||
**Gradual | |||
**[[Meningitis (Peds)|Meningitis]] more likely | |||
*Consider if feeding disturbance, rash, lethargy, irritability, [[seizure]], apnea, tachypnea, grunting, vomiting, poor PO, gastric distention, [[diarrhea]] | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 69: | Line 71: | ||
#**Consider use of [[ketamine]] for sedation (less hypotension) | #**Consider use of [[ketamine]] for sedation (less hypotension) | ||
#**Be prepared for cardiovascular collapse | #**Be prepared for cardiovascular collapse | ||
#Consider corticosteroids | #Consider corticosteroids<ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | ||
#Continue to reassess (see below) | #Continue to reassess (see below) | ||
| Line 87: | Line 89: | ||
'''OR''' | '''OR''' | ||
*[[Carbapenem]] ± [[aminoglycoside]] ± [[vancomycin]] | *[[Carbapenem]] ± [[aminoglycoside]] ± [[vancomycin]] | ||
{{Infant fever well antibiotics}} | |||
===Fluid Resuscitation=== | ===Fluid Resuscitation=== | ||
| Line 97: | Line 101: | ||
**Myocardial dysfunction | **Myocardial dysfunction | ||
**Shock in the setting of fluid overload | **Shock in the setting of fluid overload | ||
**Continue to have abnormal perfusion after 40 | **Continue to have abnormal perfusion after 40-60 mL/kg of fluid resuscitation | ||
*1st line: [[epinephrine]] or [[norepinephrine]] (i.e., ''not'' dopamine)<ref>Marik PE. Dopamine increases mortality in pediatric septic shock. Journal of Pediatrics. January 2016, Volume 168, Pages 253–256.</ref><ref>Ventura AM, Shieh HH, Bousso A, Goes PF, Fernandes IC, de Souza DC, et al. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus [[Epinephrine]]as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med 2015;43:2292-302. </ref> | *1st line: [[epinephrine]] or [[norepinephrine]] (i.e., ''not'' dopamine)<ref>Marik PE. Dopamine increases mortality in pediatric septic shock. Journal of Pediatrics. January 2016, Volume 168, Pages 253–256.</ref><ref>Ventura AM, Shieh HH, Bousso A, Goes PF, Fernandes IC, de Souza DC, et al. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus [[Epinephrine]]as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med 2015;43:2292-302. </ref><ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | ||
*2nd and 3rd line: consider [[epinephrine]], [[norepinephrine]], [[dobutamine]], milrinone, [[vasopressin]], angiotensin II | *2nd and 3rd line: consider [[epinephrine]], [[norepinephrine]], [[dobutamine]], [[milrinone]], [[vasopressin]], angiotensin II<ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | ||
===Corticosteroids=== | |||
*Intravenous [[hydrocortisone]] recommended only for children with fluid-refractory, catecholamine-resistant shock.<ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | |||
**There are no data on the addition of fludrocortisone to enhance the mineralocorticoid effect in pediatric septic shock.<ref>Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967</ref> | |||
===Reevaluation=== | ===Reevaluation=== | ||
Latest revision as of 22:42, 5 July 2025
This page is for pediatric patients. For adult patients, see: Sepsis.
Background
- Defined as a dysregulated host response to infection that leads to life-threatening organ dysfunction[1]
- Tachycardia is typically most predominant, hypotension is a late and ominous sign
Clinical Features
Shock: Warm vs Cold Shock
| Warm Shock | Cold Shock | |
|---|---|---|
| Peripheries | Warm, Flushed | Mottled, Cold, Clammy |
| Cap Refill | <2 sec | >2 sec |
| Pulse | Bounding | Weak, Thready |
| BP | Compensated | Hypotension |
| HR | Tachy | Tachy or Brady |
| Pulse Pressure | Widen | Narrow |
Neonatal Sepsis
- Early onset
- First few days of life
- Fulminant, associated with maternal or perinatal risk factors
- Septic shock and neutropenia are more common
- Late onset
- Occurs after 1 week of age
- Gradual
- Meningitis more likely
- Consider if feeding disturbance, rash, lethargy, irritability, seizure, apnea, tachypnea, grunting, vomiting, poor PO, gastric distention, diarrhea
Differential Diagnosis
Sick Neonate
THE MISFITS [2]
- Trauma
- Heart
- Congenital heart disease
- Hypovolemia
- Endocrine
- Metabolic
- Sodium
- Calcium
- Glucose
- Inborn errors of metabolism
- Seizure
- Formula / feeding problems
- Intestinal Disasters
- Toxin
- Sepsis
Pediatric fever
- Upper respiratory infection (URI)
- UTI
- Sepsis
- Meningitis
- Febrile seizure
- Juvenile rheumatoid arthritis
- Pneumonia
- Acute otitis media
- Whooping cough
- Unclear source
- Kawasaki disease
- Neonatal HSV
- Specific virus
Evaluation
Work-Up
- CBC, CMP
- Coags, D-dimer, fibrinogen
- Lactate, CRP
- Blood glucose
- Urinalysis/urine culture
- CXR
- Blood cultures
- Consider LP for CSF
Diagnosis
- Initial screening and decision to send studies is based on provider judgement
- Use the Phoenix Sepsis Score to calculate sepsis criteria, including septic shock.[3][4]
- Not indicated for adults, preterm (<37 weeks), or peri-birth hospitalizations
Management
Initial Resuscitation Focus
- Treat hypoxemia with supplemental oxygen (goal SpO2 92-98%)[5]
- Obtain intravenous/intraosseous access
- Rapidly transition to IO access, if difficulties with starting IV
- Collect diagnostic tests (including blood culture, lactate, ionized calcium; see workup above)
- Treat hypoglycemia, if present
- Early empiric broad-spectrum antibiotics (see below)
- Administer bolus intravenous fluid therapy administration (see below), if shock is present
- Start vasoactive agents, if shock persists
- Airway
- Consider CPAP (may buy time for fluid resuscitation prior intubation)
- Consider intubation, especially in fluid refractory shock
- Consider use of ketamine for sedation (less hypotension)
- Be prepared for cardiovascular collapse
- Consider corticosteroids[6]
- Continue to reassess (see below)
Empiric Broad-Spectrum Antibiotics
If in shock, administer as soon as possible. If not, it is reasonable to perform expedited diagnostics before administration.[7]
Neonatal
- Ampicillin 50mg/kg q8h + gentamicin 2.5mg/kg q24h + acyclovir
- If gram-negative strongly suspected replace gentamicin with cefotaxime or ceftazadine
- Have better CNS penetration
- If gram-negative strongly suspected replace gentamicin with cefotaxime or ceftazadine
Peds
Treatment will differ by local protocols
- Extended-spectrum penicillin (e.g. piperacillin-tazobactam) ± aminoglycoside ± vancomycin
OR
- 3rd or 4th generation cephalosporin ± aminoglycoside ± vancomycin
OR
Neonatal Antibiotics by Source[8]
| Suspected Infection Source | 8-21 Days Old | 22-28 Days Old | 29-60 Days Old |
| UTI |
|
|
|
| No source identified |
|
|
|
| Bacterial meningitis |
|
|
|
Fluid Resuscitation
- For shock, 20 mL/kg boluses of isotonic crystalloid fluid titrated to clinical markers of cardiac output[9]
- Frequently ≥40 mL/kg in the first hour of resuscitation
- In low-resource settings (e.g., low income countries), fluid bolus therapy should be avoided unless the child exhibits hypotension[10]
Vasopressors
- Indicated for children that have:
- Myocardial dysfunction
- Shock in the setting of fluid overload
- Continue to have abnormal perfusion after 40-60 mL/kg of fluid resuscitation
- 1st line: epinephrine or norepinephrine (i.e., not dopamine)[11][12][13]
- 2nd and 3rd line: consider epinephrine, norepinephrine, dobutamine, milrinone, vasopressin, angiotensin II[14]
Corticosteroids
- Intravenous hydrocortisone recommended only for children with fluid-refractory, catecholamine-resistant shock.[15]
- There are no data on the addition of fludrocortisone to enhance the mineralocorticoid effect in pediatric septic shock.[16]
Reevaluation
- Patients should be continuously reassessed for signs of:
- Ongoing or worsening shock
- Iatrogenic fluid overload (e.g., pulmonary rales, hepatomegaly, peripheral edema, and echocardiographic findings that may suggest fluid overload)
- Golden Hour Goals
- Cap refill <2 sec
- Normal BP
- Normal pulses, similar central and peripheral
- Warm extremities
- UOP >1 mL/kg/hr
- Normal mental status
Disposition
- Admit
See Also
External Links
References
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Brousseau T, Sharieff GQ. Newborn emergencies: the first 30 days of life. Pediatr Clin North Am. 2006 Feb;53(1):69-84, vi.
- ↑ Schlapbach LJ, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024 Feb 27;331(8):665-674. doi: 10.1001/jama.2024.0179.
- ↑ Sanchez-Pinto LN, et al. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024 Feb 27;331(8):675-686. doi: 10.1001/jama.2024.0196.
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Marik PE. Dopamine increases mortality in pediatric septic shock. Journal of Pediatrics. January 2016, Volume 168, Pages 253–256.
- ↑ Ventura AM, Shieh HH, Bousso A, Goes PF, Fernandes IC, de Souza DC, et al. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrineas First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med 2015;43:2292-302.
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
- ↑ Weiss SL, Fitzgerald JC. Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes. Pediatrics (2024) 153 (1): e2023062967. https://doi.org/10.1542/peds.2023-062967
